This invention relates to indo line compounds of the structural formula I, or their pharmaceutically acceptable salts, wherein the variables are defined herein. The inventive compounds selectively inhibit aldosterone synthase. This invention also provides for pharmaceutical compositions comprising the compounds of Formula I or their salts as well as potentially to methods for the treatment amelioration or prevention of conditions that could be treated by inhibiting aldosterone synthase.
本发明涉及结构式I的印度线化合物或其药学上可接受的盐,其中变量在此定义。这些创新化合物可选择性地抑制
醛固酮合成酶。本发明还提供了包含式I化合物或其盐的制药组合物,以及可能用于治疗、改善或预防通过抑制
醛固酮合成酶可治疗的疾病的方法。